HER2 Support Group Forums - View Single Post - OncoSec reports net loss of $7.0 million for first quarter of fiscal 2016

News · 12-08-2015, 06:50 AM

OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced financial results for the first quarter of fiscal year ended July 31, 2016.

More...

12-08-2015, 06:50 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	OncoSec reports net loss of $7.0 million for first quarter of fiscal 2016 OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced financial results for the first quarter of fiscal year ended July 31, 2016. More...